- Home
- TTOO vs AEI Comparison
TTOO vs AEI Comparison
Compare TTOO & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- AEI
- Stock Information
- Founded
- TTOO 2006
- AEI 2014
- Country
- TTOO United States
- AEI United States
- Employees
- TTOO N/A
- AEI N/A
- Industry
- TTOO Medical/Dental Instruments
- AEI Building operators
- Sector
- TTOO Health Care
- AEI Real Estate
- Exchange
- TTOO Nasdaq
- AEI Nasdaq
- Market Cap
- TTOO 10.7M
- AEI 12.0M
- IPO Year
- TTOO 2014
- AEI N/A
- Fundamental
- Price
- TTOO $0.27
- AEI $0.82
- Analyst Decision
- TTOO Hold
- AEI
- Analyst Count
- TTOO 1
- AEI 0
- Target Price
- TTOO $5.00
- AEI N/A
- AVG Volume (30 Days)
- TTOO 877.9K
- AEI 2.8M
- Earning Date
- TTOO 02-13-2025
- AEI 11-14-2024
- Dividend Yield
- TTOO N/A
- AEI N/A
- EPS Growth
- TTOO N/A
- AEI N/A
- EPS
- TTOO N/A
- AEI N/A
- Revenue
- TTOO $7,677,000.00
- AEI $13,191,488.00
- Revenue This Year
- TTOO $50.31
- AEI N/A
- Revenue Next Year
- TTOO $117.92
- AEI N/A
- P/E Ratio
- TTOO N/A
- AEI N/A
- Revenue Growth
- TTOO N/A
- AEI N/A
- 52 Week Low
- TTOO $0.25
- AEI $0.46
- 52 Week High
- TTOO $6.95
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- TTOO 25.65
- AEI 40.86
- Support Level
- TTOO $0.25
- AEI $0.83
- Resistance Level
- TTOO $0.43
- AEI $0.92
- Average True Range (ATR)
- TTOO 0.04
- AEI 0.27
- MACD
- TTOO -0.00
- AEI -0.02
- Stochastic Oscillator
- TTOO 7.80
- AEI 3.80
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.